BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9916901)

  • 1. Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae.
    Lacy MK; Owens RC; Xu X; Nicolau DP; Quintiliani R; Nightingale CH
    Int J Antimicrob Agents; 1998 Nov; 10(4):279-83. PubMed ID: 9916901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative serum bactericidal activity of clarithromycin and azithromycin against macrolide-sensitive and resistant strains of Streptococcus pneumoniae.
    Stein GE; Schooley S
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):181-5. PubMed ID: 11337186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bactericidal activity of extended-release clarithromycin against macrolide-resistant strains of Streptococcus pneumoniae.
    Stein GE; Schooley S
    Pharmacotherapy; 2002 May; 22(5):593-6. PubMed ID: 12013358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae.
    Noreddin AM; El-Khatib WF; Aolie J; Salem AH; Zhanel GG
    Int J Infect Dis; 2009 Jul; 13(4):483-7. PubMed ID: 19046911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
    Waites K; Swiatlo E; Gray B; Brookings E
    South Med J; 1997 Jun; 90(6):621-6. PubMed ID: 9191739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
    Ednie LM; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics.
    Kays MB; Denys GA
    Clin Ther; 2001 Mar; 23(3):413-24. PubMed ID: 11318076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro, in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniae.
    Pérez-Trallero E; Alkorta M; García-Arenzana JM; Iturzaeta A; Gomariz M
    J Antimicrob Chemother; 1998 Jun; 41(6):629-34. PubMed ID: 9687101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
    Dan M; Poch F; Edelman A; Asherov J; Hafely H; Atzmon Y
    J Antimicrob Chemother; 1998 Apr; 41(4):485-8. PubMed ID: 9598780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia.
    Shibl AM; Al Rasheed AM; Elbashier AM; Osoba AO
    J Chemother; 2000 Apr; 12(2):134-7. PubMed ID: 10789552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae.
    Martin SJ; Garvin CG; McBurney CR; Sahloff EG
    J Antimicrob Chemother; 2001 May; 47(5):581-7. PubMed ID: 11328768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
    McLinn S; Williams D
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model.
    Hoffman HL; Klepser ME; Ernst EJ; Petzold CR; Sa'adah LM; Doern GV
    Antimicrob Agents Chemother; 2003 Feb; 47(2):739-46. PubMed ID: 12543686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
    Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
    Conte JE; Golden J; Duncan S; McKenna E; Lin E; Zurlinden E
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1617-22. PubMed ID: 8807050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
    Dagan R; Abramson O; Leibovitz E; Lang R; Goshen S; Greenberg D; Yagupsky P; Leiberman A; Fliss DM
    Pediatr Infect Dis J; 1996 Nov; 15(11):980-5. PubMed ID: 8933545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bactericidal activity of gemifloxacin versus clarithromycin against Streptococcus pneumoniae with different susceptibility to quinolones.
    Malerczyk C; Kolbert M; Kinzig-Schippers M; Sörgel F; Machka K; Shah PM
    J Chemother; 2004 Feb; 16(1):56-61. PubMed ID: 15078000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
    Visalli MA; Jacobs MR; Appelbaum PC
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of clarithromycin against penicillin-susceptible and penicillin-resistant strains of Streptococcus pneumoniae in a pharmacodynamic simulation model.
    Fuentes F; Sevillano D; Balcabao IP; Gómez-Lus ML; Prieto J
    J Chemother; 2000 Dec; 12(6):495-8. PubMed ID: 11154032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.